Related Experiment Video
Updated: Dec 24, 2025
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Shelter Hospital: Glimmers of Hope in Treating Coronavirus 2019
Feng Zhou1, Xuan Gao1, Mengwei Li2
1Department of Endocrinology, Puren Hospital of Wuhan University of Science and Technology, Wuhan, China.
Insights
Deployable rapid-assembly shelter hospitals unexpectedly aided in preventing and treating COVID-19. This approach offers valuable experience for managing future public health emergencies globally.
Area of Science:
- Public Health
- Infectious Diseases
- Emergency Medicine
Background:
- The 2019 novel coronavirus disease (COVID-19) outbreak rapidly evolved globally.
- As of March 17, 2020, over 185,000 cases were confirmed worldwide.
- Effective strategies for managing public health emergencies are crucial.
Purpose of the Study:
- To report the beneficial effects of deployable rapid-assembly shelter hospitals in managing COVID-19.
- To share experiences in shelter hospital maintenance and treatment protocols.
- To provide insights for international preparedness during health crises.
Main Methods:
- Description of a deployable rapid-assembly shelter hospital.
- Outline of the shelter hospital's maintenance procedures.
- Explanation of the treatment model and primary methods employed.
Main Results:
- Shelter hospitals demonstrated an unexpected beneficial effect on COVID-19 prevention and treatment.
- The implemented treatment modes and methods were effective in managing cases.
- The experience gained is valuable for future public health responses.
Conclusions:
- Deployable rapid-assembly shelter hospitals are a viable and effective resource during pandemics.
- Sharing operational experiences can enhance global preparedness for infectious disease outbreaks.
- This model offers practical solutions for managing large-scale public health emergencies like COVID-19.
Abstract:
Since the first report of the 2019 novel coronavirus disease (COVID-19) in December 2019 in Wuhan, China, the outbreak of the disease has been continuously evolving. Until March 17, 2020, 185, 178 cases had been confirmed, including 81,134 cases in China and 104,044 cases outside of China. In this comment, we report the unexpected beneficial effect of a deployable rapid-assembly shelter hospital on the prevention and treatment of COVID-19. We describe the shelter hospital maintenance, treatment mode and primary treatment methods, which will provide a valuable experience in dealing with public health emergencies, such as COVID-19, for other countries and areas.
Related Concept Videos
01:28Hospitals-I
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
00:59Hospitals-II
Nurses that work in...
01:30Specialized Care Centers and Settings-II
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
01:29Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...